- CONMED Corp (NYSE:CNMD) is withdrawing its FY22 financial outlook, citing a temporary disruption resulting from implementing new warehouse management software.
- In recent weeks, the company began implementing new software designed to increase the efficiency and performance of its primary distribution facility.
- The implementation of this new software created shipping disruptions that lasted longer than initially projected.
- CONMED cannot fully assess the impact on fourth-quarter sales and profitability as it continues to incur costs while working to reduce the shipping backlog.
- Daily shipment volumes have returned to normal levels, and the company has reduced the shipping backlog from a peak of approximately $35 million last week to approximately $28 million today.
- CONMED believes the backlog of open orders will be shipped in the coming weeks and anticipates the impact on business performance will be limited to the fourth quarter of 2022.
- CONMED expected FY22 sales of $1.1-$1.115 billion, with adjusted EPS of $3.21-$3.28, versus the consensus of $1.11 billion and $3.28, respectively.
- For the full-year 2023, the company expects reported revenue of $1.170-$1.230 billion (consensus $1.21 billion) and adjusted EPS of $3.20-$3.50 (consensus $3.39).
- Price Action: CNMD shares traded higher by 1.96% at $90.84 on the last check Tuesday.
Envela Q2 EPS $0.14 Beats $0.10 Estimate, Sales $42.60M Beat $37.75M Estimate
Envela (AMEX:ELA) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.10 by 40 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last
